Historical record - last NADAC publication: 8/21/2019
Product Information
FIRVANQ 25 MG/ML SOLUTION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $0.6636 per ML under NDC 65628020405. Its NADAC has been published 52 times since Aug 21, 2019.
Manufacturer
Azurity Pharmaceuticals Inc.NDC
65628020405
Classification
Brand
Dosage Form
KIT
Last Updated
8/21/2019
Approval Type
New Drug (NDA)
FDA Application
NDA208910On Market Since
1/26/2018
Price Statistics
The NADAC for FIRVANQ 25 MG/ML SOLUTION has been published 52 times since Aug 21, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6636 per ML |
|---|---|
| All-time high | $0.6636 (Aug 12, 2020) |
| All-time low | $0.6636 (Aug 21, 2019) |
| Median price | $0.6636 |
| Average price | $0.6636 |
| Largest weekly change | 0.0% (Aug 28, 2019) |
| Weeks tracked | 52 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FIRVANQ 25 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for FIRVANQ 25 MG/ML SOLUTION, manufactured by Azurity Pharmaceuticals Inc., is $0.6636 per ML (NDC 65628020405), effective Aug 12, 2020.
How has the price of FIRVANQ 25 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for FIRVANQ 25 MG/ML SOLUTION has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for FIRVANQ 25 MG/ML SOLUTION?
Since Aug 21, 2019, the NADAC for FIRVANQ 25 MG/ML SOLUTION has ranged from a low of $0.6636 (Aug 21, 2019) to a high of $0.6636 (Aug 12, 2020), with a median of $0.6636 per ML.
Are there cheaper alternatives to FIRVANQ 25 MG/ML SOLUTION?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VANCOMYCIN 25 MG/ML ORAL SOLN, is $0.4082 per ML — about 38% below FIRVANQ 25 MG/ML SOLUTION.
Who manufactures FIRVANQ 25 MG/ML SOLUTION?
FIRVANQ 25 MG/ML SOLUTION (NDC 65628020405) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification